Transaction Details

Footnotes

Represents stock options that the Reporting Person was entitled to receive pursuant to the non-employee director compensation policy of Werewolf Therapeutics, Inc. (the "Company") in effect at the time of the Reporting Person's appointment to the board of directors of the Company, which were not previously granted due to a clerical error. | The option was granted on June 11, 2025. One-third of the total number of shares underlying the option vest on February 19, 2026, and the remaining shares vest thereafter in equal monthly installments until February 19, 2028, subject to continued service by the Reporting Person as a director to the Company through each applicable vesting date. | The option was granted on June 12, 2025. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.